Skip to main content

Table 1 Characterization of the patients from Brazil, Latin America and World

From: Insulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World data

 Characteristic Brazil N Brazil LatAm N LatAm World N World
T1DM 25% 64 31% 183 21% 2790
T2DM 73% 187 68% 408 41% 5378
Other/Not responded 2% 4 1% 8 38% 5057
 Age (years) 53.0 (18.9) 255 49.8 (20.1) 599 51.9 (18.1) 13,225
 BMI* 28.2 (6.1) 252 27.9 (6.0) 574 26.6 (6.2) 12,806
 Years with DM (years) 15.6 (9.5) 248 13.6 (9.6) 572 13.2 (9.7) 9197
 Age at diagnosis (years) 36.7 (17.5) 231 35.9 (18.3) 562 39.9 (7.2) 12,737
 Years on pills 14.8 (9.8) 148 13.3 (9.5) 272 8.3 (7.2) 6607
 Years on insulin 9.8 (8.5) 234 8.2 (7.9) 515 8.7 (8.9) 8242
 TDD regular (Units) 12.2 (9.8) 86 13.9 (9.9) 167 27.0 (20.7) 1422
 TDD rapid analogues 17.2 (11.5) 39 18.9 (11.4) 150 31.9 (21.6) 3467
 TDD NPH 39.3 (26.8) 219 37.6 (23.8) 391 31.6 (24.4) 1134
 TDD basal analogues 34.8 (14.7) 31 26.9 (13.1) 186 27.6 (19.5) 4709
 TDD premix 136 1 62.4 (48.3) 7 43.0 (25.3) 1796
 Overall TDD 45.9 (30.9) 242 42.5 (26.5) 579 48.5 (32.4) 7756
 HbA1c (%) 8.45 (1.8) 163 8.34 (1.8) 460 8.47 (2.1) 7663
  1. BMI body max index (calculated as the weight in kilograms divided by the height in meters squared), DM diabetes mellitus, T1DM type 1 diabetes mellitus, T2DM type 2 diabetes mellitus, TDD total daily dose, NPH neutral protamine Hagedorn, HbA1c glycated hemoglobin (%[mmol/mol])